Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PI3K/VEGFR2-IN-1 is a potent dual inhibitor targeting both PI3K and VEGFR2 with IC50 values of 2.21 μM for PI3K and 68 μM for VEGFR2, respectively. This compound also induces apoptosis and is utilized in cancer research [1].
説明 | PI3K/VEGFR2-IN-1 is a potent dual inhibitor targeting both PI3K and VEGFR2 with IC50 values of 2.21 μM for PI3K and 68 μM for VEGFR2, respectively. This compound also induces apoptosis and is utilized in cancer research [1]. |
ターゲット&IC50 | PI3K:2.21 μM, VEGFR2:68 μM |
In vitro | PI3K/VEGFR2-IN-1 (compound 8; 1.56-100 µM; 24 h; HePG2, MCF-7, Hela, and PC3 cells) dose-dependently inhibits proliferation, while at a concentration of 10 mg/mL and 24-hour exposure, it induces G1/S phase cell cycle arrest and apoptosis in MCF-7 and Hela cells [1]. |
分子量 | 343.83 |
分子式 | C17H14ClN3OS |
CAS No. | 2851067-08-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PI3K/VEGFR2-IN-1 2851067-08-6 PI3K/Akt/mTOR signaling PI3K Inhibitor inhibitor inhibit